Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Singh, D
  • Bafadhel, M
  • Brightling, CE
  • Rabe, KF
  • Han, MK
  • Bhutani, M
  • Bourbeau, J
  • Christenson, SA
  • Dransfield, MT
  • Nair, Parameswaran Krishna
  • Kotalik, A
  • Hellqvist
  • Almqvist, G
  • Sindhwani, NS
  • Gołąbek, M
  • Molfino, NA
  • Ponnarambil, SS
  • on behalf of the COURSE study investigators

publication date

  • May 2024